The Use of Nimesulide and Its Analogues in Cancer Chemoprevention

Author(s): Jean-Francois Renard, Fabien Julemont, Xavier d. Leval, Bernard Pirotte

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 6 , Issue 3 , 2006

Become EABM
Become Reviewer


Non-steroidal anti-inflammatory drugs (NSAIDs), which are known to be cyclooxygenase (COX) inhibitors, have been reported to exert anti-proliferative and pro-apoptotic effects on a variety of cancer cells. Since the COX-2 isoform was found to be overexpressed in a many human cancers, a particular attention was paid on the possible use of selective COX-2 inhibitors in cancer chemoprevention. The present review focuses on the state of the art in cancer research developed with COX-2 preferential/selective inhibitors belonging to the family of N-arylmethanesulfonamides, in particular nimesulide and NS-398.

Keywords: Nimesulide, NS-398, cancer chemoprevention, NSAIDs, cyclooxygenase inhibitors, anti-proliferative, proapoptotic, N-arylmethanesulfonamides

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [233 - 237]
Pages: 5
DOI: 10.2174/187152006776930855
Price: $65

Article Metrics

PDF: 4